Chemours (CC) Current Deferred Revenue (2016 - 2021)
Chemours (CC) has 7 years of Current Deferred Revenue data on record, last reported at $3.0 million in Q4 2021.
- For Q4 2021, Current Deferred Revenue fell 57.14% year-over-year to $3.0 million; the TTM value through Dec 2021 reached $3.0 million, down 57.14%, while the annual FY2021 figure was $3.0 million, 57.14% down from the prior year.
- Current Deferred Revenue reached $3.0 million in Q4 2021 per CC's latest filing, up from $2.0 million in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $23.0 million in Q1 2017 and bottomed at $2.0 million in Q3 2021.
- Average Current Deferred Revenue over 5 years is $7.3 million, with a median of $7.0 million recorded in 2019.
- Peak YoY movement for Current Deferred Revenue: crashed 89.47% in 2017, then surged 60.0% in 2019.
- A 5-year view of Current Deferred Revenue shows it stood at $8.0 million in 2017, then decreased by 25.0% to $6.0 million in 2018, then grew by 16.67% to $7.0 million in 2019, then changed by 0.0% to $7.0 million in 2020, then crashed by 57.14% to $3.0 million in 2021.
- Per Business Quant database, its latest 3 readings for Current Deferred Revenue were $3.0 million in Q4 2021, $2.0 million in Q3 2021, and $3.0 million in Q2 2021.